Comparative study of clinical efficacy of amitriptyline and pregabalin in postherpetic neuralgia.

The most common complication of herpes zoster in immunocompetent patients is postherpetic neuralgia, which is very difficult to treat. Significant beneficial effects have been found for amitriptyline, gabapentin, pregabalin, carbamazepine, sodium valproate, oxycodone, corticosteroid, topical capsaicin, tramadol, etc. The aim of this open randomized comparative study was to demonstrate clinical efficacy of amitriptyline and pregabalin. The study included 50 patients, 32 (64%) male and 18 (36%) female, randomized to receive either amitriptyline or pregabalin (n=25 each). Amitriptyline was administered in a dose of 25 mg once daily and pregabalin in a dose of 75 mg twice daily. Inclusion criteria were as follows: postherpetic neuralgia of more than 1 month duration; pain of at least moderate severity; and patient age 40 years or older and no pregnancy. Patients with a history of any serious diseases (renal, cardiac, hepatic or seizure) were excluded. Total treatment period spanned 8 weeks, with patient follow up visits at 2, 4 and 8 weeks to assess the degree of improvement in pain perception and any adverse reaction. Patients with four herpes zoster types were included in this study, of which thoracic type predominated (54%). Other types were cervical in 12 (24%), trigeminal in 8 (16%) and lumbosacral in 3 (6%) patients. Prodromal symptoms before herpes zoster were reported by 66% of study patients. Satisfactory improvements of pain perception at the end of 8 weeks (>75%) were noticed in pregabalin group, which was statistically significant (χ(2)2=10.08; P<0.05). Dry mouth was the commonest complication in amitriptyline group and dizziness in pregabalin group. More importantly, none of the patients stopped treatment due to adverse reaction. In conclusion, therapy with pregabalin is better compared to amitriptyline in postherpetic neuralgia patients. However, a similar study in a larger sample is required to validate the present findings.

[1]  J. Ballenger.  Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial , 2011 .

[2]  井福 正貴.  Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy , 2011 .

[3]  S. Ogawa,et al.  [Long-term efficacy and safety of pregabalin in patients with postherpetic neuralgia: results of a 52-week, open-label, flexible-dose study]. , 2010, Masui. The Japanese journal of anesthesiology.

[4]  G. Chatterjee,et al.  Comparative study of clinical efficacy with amitriptyline, pregabalin, and amitriptyline plus pregabalin combination in postherpetic neuralgia. , 2010, Indian journal of dermatology, venereology and leprology.

[5]  Yong Chul Kim,et al.  Treatment of Herpes Zoster and Postherpetic Neuralgia , 2008 .

[6]  B. Yawn,et al.  A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. , 2007, Mayo Clinic proceedings.

[7]  J. Stockman.  A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults , 2007 .

[8]  J. T. Cox.  Epidemiology and natural history of HPV. , 2006, The Journal of family practice.

[9]  N. Shafiq,et al.  Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial. , 2006, International journal of clinical pharmacology and therapeutics.

[10]  R. Dworkin,et al.  Acute pain in herpes zoster and its impact on health-related quality of life. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  R. Stolker,et al.  Interventions to prevent postherpetic neuralgia: cutaneous and percutaneous techniques , 2004, Pain.

[12]  P. Manfredi.  Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial , 2003, Neurology.

[13]  K. Schmader.  Epidemiology and Impact on Quality of Life of Postherpetic Neuralgia and Painful Diabetic Neuropathy , 2002, The Clinical journal of pain.

[14]  S J Soong,et al.  Phase specific analysis of herpes zoster associated pain data: a new statistical approach , 2001, Statistics in medicine.

[15]  M. Rowbotham,et al.  Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. , 1998, JAMA.

[16]  K. Schmader.  Postherpetic neuralgia in immunocompetent elderly people. , 1998, Vaccine.

[17]  L. Vernich,et al.  Nortriptyline versus amitriptyline in postherpetic neuralgia , 1998, Neurology.

[18]  R. Dworkin,et al.  Pain and its persistence in herpes zoster , 1996, Pain.

[19]  D. Friedman,et al.  Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults , 1995, Antimicrobial agents and chemotherapy.

[20]  R. Dworkin,et al.  Proposed classification of herpes zoster pain , 1994, The Lancet.

[21]  M. Chipman,et al.  Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial , 1992, Pain.

[22]  J. Loeser.  Herpes zoster and postherpetic neuralgia , 1986, Pain.

[23]  H. Merskey,et al.  Amitriptyline versus placebo in post-herpetic neuralgia , 1981, PAIN.